Vitamin
D May Protect
Cells From
Cancer-Causing Stress
By inducing a specific gene to increase expression of a key enzyme,
vitamin D protects healthy prostate cells from the damage and injuries
that can lead to cancer, University of Rochester Medical Center researchers
report.
“Many epidemiological studies have suggested
the beneficial properties of vitamin D,” said Yi-Fen Lee, associate
professor of urology and research leader. “Our findings reflect
what we see in those studies and demonstrate that vitamin D not only
can be used as a therapy for prostate cancer, it also can prevent
prostate cancer from developing.”
The International Journal of Cancer will publish
the findings in its June 15 issue.
The vitamin D used in the study
is 1, 25-hydroxylvitamin D3, the most potent and active form of vitamin
D in the human body. Nonmalignant human prostate epithelial cells
also were used.
Normal metabolism in cells generates reactive
oxygen species (ROS), molecules of peroxide, for example, or so-called
free radicals. These substances can play a role in cell signaling
and even kill bacteria. Exposure to some chemicals or forms of radiation
can produce high levels of ROS that can damage DNA and play a significant
role in accelerating the aging process or causing cancer.
Lee found
that vitamin D links with a gene known as G6PD, increasing its activity
and the production of an enzyme called glucose-6-phosphate dehydrogenase.
Increased activity of the enzyme clears cells of ROS, the molecules
that can damage and injure cells.
The G6PD pathway is
one of the mechanisms vitamin D uses, Lee says. However, the researchers
did not find any similar activity in prostate cancer cells, which
indicates that vitamin D does not protect cancer cells from injury
or damage.
“If you reduce DNA damage, you reduce
the risk of cancer or aging,” Lee says, but adds that large
amounts of vitamin D should not be taken without medical supervision.
In
the journal Carcinogenesis in 2006, Lee reported that vitamin D can
inhibit the spread of prostate cancer by limiting the ability of
cancer cells to invade healthy cells by reducing the activity of
two specific enzymes, proteases called matrix metalloproteinase and
cathepsin. The research was conducted in test tubes using human prostate
cancer cell lines. That finding indicated that vitamin D could provide
beneficial treatment to prostate-cancer patients with high levels
of the enzymes.
Source: ScienceDaily
[ back to top ] |